February 7, 2017 / 9:22 PM / 6 months ago

BRIEF-Gilead Sciences reports Q4 earnings per share $2.34

1 Min Read

Feb 7 (Reuters) - Gilead Sciences Inc

* Gilead Sciences announces fourth quarter and full year 2016 financial results

* Q4 non-GAAP earnings per share $2.70 excluding items

* Q4 earnings per share $2.34

* Q4 revenue $7.3 billion versus I/B/E/S view $7.15 billion

* Q4 earnings per share view $2.61 -- Thomson Reuters I/B/E/S

* Gilead Sciences Inc qtrly harvoni sales $1,640 million versus $3,345 million

* Gilead Sciences Inc qtrly sovaldi sales $541 million versus $1,547 million

* Gilead Sciences Inc sees full year 2017 net product sales $22.5 billion - $24.5 billion

* Gilead Sciences Inc sees full year 2017 net product sales $22,500 - $24,500 million

* Gilead Sciences sees 2017 diluted EPS impact of acquisition-related,up-front collaboration, stock-based compensation and other expenses $0.84 -$0.91

* Gilead Sciences Inc sees 2017 non gaap product gross margin 86% - 88% Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below